Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person lung adenocarcinoma

Class:Id	Disease:8853117
_displayName	lung adenocarcinoma
_timestamp	2016-01-21 20:38:35
created	[InstanceEdit:8853119] Rothfels, Karen, 2016-01-21
definition	A non-small cell lung carcinoma that derives_from epithelial cells of glandular origin.
identifier	3910
name	lung adenocarcinoma
referenceDatabase	[ReferenceDatabase:1247631] DOID
synonym	nonsmall cell adenocarcinoma
(disease)	[Pathway:9710421] Defective pyroptosis [Homo sapiens] [FailedReaction:9710468] GSDME variant does not bind PIPs [Homo sapiens] [EntityWithAccessionedSequence:8853132] p-6Y-FGFR2(2-822)-CIT(927-2027) fusion [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:8853154] FGFR2(2-822)-CIT(927-2027) fusion [plasma membrane] [Homo sapiens] [Complex:8853172] FGFR2(2-822)-CIT(927-2027) fusion dimer [plasma membrane] [Homo sapiens] [Complex:8853215] p-6Y FGFR2(2-822)-CIT(927-2027) fusion dimer [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:9630805] p16INK4A A20P [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:9630828] p16INK4A R24P [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:9630916] p16INK4A P114L [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:9631120] p16INK4A V126F [cytosol] [Homo sapiens] List all 198 refering instances
[Change default viewing format]

No pathways have been reviewed or authored by lung adenocarcinoma (8853117)